Khrista Boylan

Active 1983–2022

64
Papers
21,399
Citations
60
h-index
64
i10-index

Citations

Citations per year for Khrista Boylan1945: 1 citations1951: 1 citations1967: 1 citations1984: 4 citations1985: 8 citations1986: 7 citations1987: 7 citations1988: 12 citations1989: 2 citations1990: 4 citations1991: 2 citations1992: 3 citations1993: 4 citations1994: 2 citations1995: 3 citations1996: 4 citations1997: 3 citations1998: 7 citations1999: 11 citations2000: 13 citations2001: 6 citations2002: 4 citations2003: 4 citations2004: 2 citations2005: 3 citations2006: 9 citations2007: 2 citations2008: 35 citations2009: 61 citations2010: 75 citations2011: 100 citations2012: 282 citations2013: 363 citations2014: 363 citations2015: 456 citations2016: 527 citations2017: 563 citations2018: 472 citations2019: 1,226 citations2020: 1,202 citations2021: 1,095 citations2022: 742 citations2023: 583 citations2024: 732 citations2025: 331 citations2026: 13 citations1946–1950: no citations, so these years are not shown1952–1966: no citations, so these years are not shown1968–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,709 citing papers, 30% of this breakdownUnited Kingdom: 858 citing papers, 9.5% of this breakdownGermany: 572 citing papers, 6.3% of this breakdownItaly: 539 citing papers, 6% of this breakdownChina: 494 citing papers, 5.5% of this breakdownCanada: 445 citing papers, 4.9% of this breakdownAustralia: 303 citing papers, 3.3% of this breakdownNetherlands: 294 citing papers, 3.3% of this breakdownFrance: 292 citing papers, 3.2% of this breakdownJapan: 263 citing papers, 2.9% of this breakdownBelgium: 259 citing papers, 2.9% of this breakdownSpain: 235 citing papers, 2.6% of this breakdown
0%30%Other 19.6%

Fields

  • Medicine59.1%
  • Biochemistry, Genetics and Molecular Biology25.9%
  • Neuroscience11.2%
  • Psychology1.3%
  • Immunology and Microbiology0.9%
  • Agricultural and Biological Sciences0.5%
  • Other1.1%

Topics

  • Amyotrophic Lateral Sclerosis Research17.3%
  • Neurogenetic and Muscular Disorders Research9.2%
  • RNA Research and Splicing6.8%
  • Alzheimer's disease research and treatments4.9%
  • Parkinson's Disease Mechanisms and Treatments4.3%
  • Genetic Neurodegenerative Diseases4.2%
  • Other53.3%

Coauthors

All papers

Open in search
  1. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2011 cited by 4,971

  2. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Benatar, Oliver D. King, Virginia Kimonis, Eric D. Ross, Conrad C. Weihl, James Shorter, J. Paul Taylor - Nature 2013 cited by 1,518

  3. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2018 cited by 604

  4. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS

    Authors: , , , , , , , , , , , , - Neuron 2013 cited by 1,110

  5. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zbigniew K. Wszołek, Elizabeth Finger, Carol F. Lippa, David Lacomis, Heather Stewart, Dennis W. Dickson, Hong Joo Kim, Ekaterina Rogaeva, Eileen H. Bigio, Khrista Boylan, J. Paul Taylor, Rosa Rademakers - Neuron 2017 cited by 651

  6. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS

    Authors: , , , , , , , , , , , , , , , , - Acta Neuropathologica 2013 cited by 589

  7. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2015 cited by 414

  8. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis W. Dickson, Rosa Rademakers, Owen A. Ross - Molecular Neurodegeneration 2013 cited by 413

  9. C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher D. Link, Chad A. Dickey, Jeffrey D. Rothstein, Dennis W. Dickson, John Denis Fryer, Leonard Petrucelli - Nature Neuroscience 2016 cited by 322

  10. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  11. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood

    Authors: , , , , , , , , , , , , , - Acta Neuropathologica 2013 cited by 314

  12. Familial Amyotrophic Lateral Sclerosis

    Authors: - Neurologic Clinics 2015 cited by 185

  13. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress

    Authors: , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2014 cited by 340

  14. Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice

    Authors: , , , , , , , , , , , , , , , , - Journal of Neuroscience 2010 cited by 575

  15. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2015 cited by 402

  16. Chronic traumatic encephalopathy pathology in a neurodegenerative disorders brain bank

    Authors: , , , , , , , , , , , , , - Acta Neuropathologica 2015 cited by 328

  17. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carla Palmucci, A. Robertson, Michael G. Heckman, Nancy N. Diehl, Edythe Wiggs, Michael Tierney, Laura Braun, Jennifer Farren, David Lacomis, Shafeeq Ladha, Christina Fournier, Leo McCluskey, Lauren Elman, Jon B. Toledo, Jennifer D. McBride, Cinzia Tiloca, Claudia Morelli, Barbara Poletti, Federica Solca, A. Prelle, Joanne Wuu, Jennifer Jockel‐Balsarotti, Frank Rigo, Christine Ambrose, Abhishek Datta, Weixing Yang, Denitza Raitcheva, Giovanna Antognetti, Alexander McCampbell, John C. van Swieten, Bruce L. Miller, Adam L. Boxer, Robert H. Brown, Robert Bowser, Timothy M. Miller, John Q. Trojanowski, Murray Grossman, James D. Berry, William T. Hu, Antonia Ratti, Bryan J. Traynor, Matthew D. Disney, Michael Benatar, Vincenzo Silani, Jonathan D. Glass, Mary Kay Floeter, Jeffrey D. Rothstein, Khrista Boylan, Leonard Petrucelli - Science Translational Medicine 2017 cited by 268

  18. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2007 cited by 642

  19. Discovery of a Biomarker and Lead Small Molecules to Target r(GGGGCC)-Associated Defects in c9FTD/ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2014 cited by 361

  20. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Acta Neuropathologica 2015 cited by 314

  21. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2015 cited by 257

  22. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian R. Mackenzie, William W. Seeley, Lea T. Grinberg, Bruce L. Miller, Khrista Boylan, Neill R. Graff‐Radford, Bradley F. Boeve, Dennis W. Dickson, Rosa Rademakers - Acta Neuropathologica 2014 cited by 158

  23. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rosa Rademakers - PLoS Genetics 2008 cited by 463

  24. A yeast functional screen predicts new candidate ALS disease genes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Albert C. Ludolph, Wim Robberecht, Peter M. Andersen, Garth A. Nicholson, Ian P. Blair, Oliver D. King, Nancy M. Bonini, Vivianna M. Van Deerlin, Rosa Rademakers, Zissimos P. Mourelatos, Aaron D. Gitler - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 cited by 398